Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
about
Efficacy of psychostimulant drugs for amphetamine abuse or dependenceEfficacy of Psychostimulant Drugs for Amphetamine Abuse or DependenceQuality of life among treatment seeking methamphetamine-dependent individuals.Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamineEvent-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.Nonmedical use of prescription stimulants and depressed mood among college students: frequency and routes of administrationPsychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors.Depression and executive dysfunction contribute to a metamemory deficit among individuals with methamphetamine use disorders.Psychiatric comorbidity in methamphetamine dependence.Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area.Cluster randomized controlled trial of a psycho-educational intervention for people with a family history of depression for use in general practice.Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.Methamphetamine-using parents: the relationship between parental role strain and depressive symptoms.Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatientsComorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial.Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.The moderating effects of group cognitive-behavioral therapy for depression among substance users.Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community.Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: disentangling person and time-level effects.Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression.12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model.Decreased frontal lobe phosphocreatine levels in methamphetamine users.Mother-son relationship as a risk factor for depressive symptoms among methamphetamine usersA randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersEffects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.Methamphetamine psychosis: epidemiology and managementNational trends in psychostimulant-related deaths: 1999-2009.Psychostimulant-related deaths among former inmates.The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.Mental health correlates of drug treatment among women who use methamphetamine.Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice.Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users.Stimulant use disorders: characteristics and comorbidity in an Australian population sample.Psychoactive Substance Use among Methadone Maintenance Therapy Clients in China.
P2860
Q24198261-5E8E6351-68C1-4A6D-A8AA-5193552E57A9Q24203609-DE575398-CD3E-4F3A-8085-1D9B3A79AFC3Q33632417-17407F06-7FFA-40A7-93CF-FDC7E91B8544Q34022333-94D04D66-C0F2-423B-9623-37DC0CFD1882Q34219147-7EABBDFE-7722-4D88-A592-4C2638FC1245Q34313821-6FDB4E11-2A18-4A67-B2CB-F5C4CBCD689FQ34404592-085742D3-ABE7-4FFF-A57B-67CACBB6C8ADQ34604255-39FAB1A4-6B26-4627-AAD4-0E82263977CBQ34682603-2DC7DFCC-53CC-4D56-82F4-652DC3956E36Q34980327-06951235-EDF8-4EA1-9D17-8BFC94B924F4Q35056717-7F0F3D13-F3DF-47B9-B000-C5DEFC2C2A56Q35174547-AAC6F14F-4CAE-469F-8750-FA11EC602BDDQ35174572-CB174AD0-FA52-4634-ABAB-87EABAA93245Q35235473-1626723E-253E-4CD5-9580-A1EEABD126D4Q35538181-B9C7F5BB-4FD6-4491-B6E5-BA1D3C2C2547Q35934610-6B96E9FA-CEC6-4832-9D1D-180823853B12Q36055262-3B88AD91-8116-4855-99D6-E4111D25B0DFQ36069092-CCCFC856-9987-498B-A4B7-0E8AA5118EA2Q36157211-DCA6247B-2D22-464A-BF6A-4984A320400FQ36173333-89A047EA-0717-4D62-9ACF-97163D8FE91AQ36297285-A5FAC3B7-254D-4F16-8225-97F16921BB52Q36297289-7CAFB866-D598-406B-B5B1-145FC18F779DQ36303535-DBE58791-5ABA-4CF2-84CD-3784D267A6C0Q36573286-6555E8DE-7006-42C5-AEC2-FC75ED743F46Q36609285-725C0C71-AD0E-46B2-9376-410D5E6ABAFBQ36720908-DD3FC88C-E246-4995-92A7-41DB60BBD20FQ36794579-E34E8F2B-8BC7-4F99-B246-7027AFF09B80Q37157032-17C2B425-D001-433D-B049-F58FBFC2D6C2Q37265315-B822533B-E86E-4373-B680-CB2409F4B439Q37422936-A17A92A8-EF9E-4BF9-9215-D00FEB240EA4Q37443482-B66155FC-5C2D-48D7-8510-C8D837BC8131Q38825321-00F8AB2C-7052-45F9-A73E-8714C101748DQ39331415-B5631ED4-4CAA-4A80-9E01-D6362413EB23Q40307680-E6C624AA-967C-4D7D-B053-FA3A42631E61Q41020780-07B726D2-F0BA-404E-A628-0C11328E3008Q41703239-87ECAB42-8856-4238-92E3-5FA2B30E6A1DQ42709183-65A5714D-FEAA-474C-8305-6645BF8C2E0DQ42721564-982C5C80-25E6-4036-A6AB-25158BE9B7BDQ44565831-DB1284E2-8FD5-4C8B-B20C-D47B49BEE2EFQ46357502-C10749DE-F18A-4A72-87E0-98CA745F1882
P2860
Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Depression among methamphetami ...... t Project at 3-year follow-up.
@en
Depression among methamphetami ...... t Project at 3-year follow-up.
@nl
type
label
Depression among methamphetami ...... t Project at 3-year follow-up.
@en
Depression among methamphetami ...... t Project at 3-year follow-up.
@nl
prefLabel
Depression among methamphetami ...... t Project at 3-year follow-up.
@en
Depression among methamphetami ...... t Project at 3-year follow-up.
@nl
P2093
P2860
P1476
Depression among methamphetami ...... t Project at 3-year follow-up.
@en
P2093
Alfonso Ang
Larissa J Mooney
Maureen Hillhouse
Patricia Marinelli-Casey
Richard Rawson
P2860
P304
P356
10.1097/NMD.0B013E31819DB6FE
P407
P577
2009-04-01T00:00:00Z